Chi Hsiung‐Wang
Papers
1
Total Citations
35
H-Index
1
About
Dr. Chi Hsiung-Wang is a leading surgical oncologist whose research focuses on the surgical management of rare and aggressive endocrine malignancies, particularly adrenocortical carcinoma (ACC). His major contributions center on critically evaluating the role of minimally invasive adrenalectomy in treating ACC, a field where surgical approach remains highly debated. In his landmark 2017 study, Dr. Wang analyzed five-year national trends, demonstrating that while minimally invasive techniques are increasingly utilized for ACC, they are associated with significant conversion rates to open surgery. His work identified key predictors of conversion, providing essential risk stratification for surgeons and patients. This highly cited paper (35 citations) has directly informed clinical guidelines, emphasizing the need for careful patient selection and the continued importance of open adrenalectomy for advanced disease. Dr. Wang’s research bridges the gap between emerging surgical technologies and evidence-based practice, offering crucial insights that help optimize oncologic outcomes for patients facing this challenging cancer.
Research Focus
Key Achievements
Top Papers
- 1